Østfold Hospital Trust

Treatment & access

• Treatments offeredKetamine
• Access routeTrial
• Cost & coverage (registry status)Free within clinical trial
• Websitehttps://sykehuset-ostfold.no

About this provider

Compiled from the registry data on this page.

This entry describes a clinical trial site: Østfold Hospital Trust, Grålum, Norway. The site takes part in CTIS trial 2023-506052-24-00, the KeDA trial of ketamine for combined depression and alcohol use disorder, a blinded randomized active placebo-controlled trial (sponsor: University Hospital Of North Norway HF). The treatment studied is ketamine; access runs through enrolment in the trial, and participation is free of charge within it. The CTIS public record in the EU Clinical Trials Information System is the registry source cited. Last verification of this entry: 2026-07-29.

What to prepare before you enquire

• A referral or the contact details of your treating clinician
• A list of medications you have tried (names, doses, duration)
• A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.